TMO — candidate.roundup

Update

TMO — candidate.roundup

Reason: TMO is the basket's cleanest structure: +6.83% on the week at RSI 67.6, +21.1% against its 200-day and only -1.83% below its high — extended rather than an entry. MRNA bounced +6.99% but is -11.66% on the month; its +505.27% year remains the most extreme number on the desk and still has no on-file receipt behind it. AMGN recovered +2.2% after the prior cycle's drop and is still -12.82% on the month. VRTX was the only decliner (-1.38%). CRSP enters as the week's biggest move (+9.36%) and the only roster name negative on the year (-10.14%).

Price/RSI Table

Stock Price 7D 30D 52wkHi 1Y vs 200-day RSI Status Action
MRNA $154.04 +6.99% -11.66% -12.8% +505.27% +155.7% 63.3 🟢 Pullback in trend 🔒 Hold
VRTX $508.34 -1.38% -7.92% -9.27% +31.32% +8.1% 41.2 🟢 Pullback in trend 📈 Accumulate
AMGN $385.65 +2.2% -12.82% -13.73% +39.81% +7% 39.7 🟢 Pullback in trend 📈 Accumulate
TMO $651.45 +6.83% +6.18% -1.83% +35.41% +21.1% 67.6 🟢 Pullback in trend 📈 Accumulate
CRSP $56.56 +9.36% -5.43% -27.93% -10.14% +6.1% 55.2 🟢 Pullback in trend 🔍 Watch

Status reads the 200-day trend first and RSI second; Action is a trend-hold lens — an extended name is never an entry, and a name below its 200-day with a negative year is not a dip.

What Changed Since 2026-09-11

  • TMO +6.83% on the week and +6.18% on the month, RSI 67.6, +21.1% against its 200-day, +35.41% on the year. Its pull completed September 17 and returns quote pages and a second-quarter call recap — nothing dated behind this week.
  • MRNA +6.99% on the week against -11.66% on the month; +505.27% on the year, +155.7% against its 200-day. The last completed pull is August 28 — news not pulled for this move, and the magnitude stays unaccounted for.
  • AMGN +2.2% on the week, -12.82% on the month, RSI 39.7, +7% against its 200-day on a +39.81% year. Its pull is from September 11, so this week's recovery has no news pulled for it. AMGN is tracked outside the core biotech list.
  • VRTX is the only red name (-1.38%), RSI 41.2, +8.1% against its 200-day, +31.32% on the year. Its news pull failed and the file is stale (April 14) — that is a failed pull, not evidence of no news.
  • ENTRANT — CRSP: the week's biggest move at +9.36%, but -10.14% on the year with alpha -25.15 and -27.93% off its high. A bounce inside a year that has not worked; its September 17 pull returns an aggregator page only.
  • No dropouts. Nothing for these names sits in the desk's event record this week.

Sources

  • Tape data (price, RSI, returns, one-year change and alpha, distance to the 200-day): pre-computed summaries as of the 2026-09-18 close — biotech (Schwab). AMGN from biotech-scan (tracked outside the core biotech list).
  • Prior edition (format and roster only): 2026-09-11-biotech.
  • News checks: latest and .../CRSP/news/latest.json (pulled 2026-09-17), .../AMGN/news/latest.json (2026-09-11), .../MRNA/news/latest.json (2026-08-28), .../VRTX/news/latest.json (failed, stale since 2026-04-14).
10 events
DateTypeEvent
Sep 18 ScanBiotech Scan Sep 23 UpdateTMO — candidate.roundup Sep 23 ScanBiotech Scan Sep 25 UpdateTMO — candidate.roundup Sep 25 ScanBiotech Scan Sep 11 ScanBiotech Scan Oct 2 UpdateMRNA — candidate.roundup Oct 2 ScanBiotech Scan Sep 4 ScanBiotech Scan Oct 9 UpdateMRNA — candidate.roundup

No direct external sources are attached to this read.